Conduit and Sarborg complete all milestones of Phase I of their AI-driven drug development collaboration, and commence transitioning to Phase II, ...
Where did that number come from? The eagerly awaited publication of the full study from DiMasi and colleagues invites us to analyse the cost of bringing new drugs to market. $802 million.
The majority are in the very early preclinical stage of development, but applications for regulatory approval have been ...